Generate:Biomedicines | WebDisclosure

Basculer en Français

10032	Companies
204164	Keywords
134538	Articles
108308	Press releases

Headlines Articles Press releases Generate:Biomedicines

Home
Companies
Generate:Biomedicines

BRIEF

published on 12/01/2025 at 12:10, 3 months 14 days ago

Generate:Biomedicines Initiates Phase 3 Trials for Asthma Antibody GB-0895

Phase 3 Trials Generate:Biomedicines GB-0895 Asthma Treatment AI Engineered Antibody
BRIEF

published on 12/01/2025 at 12:10, 3 months 14 days ago

Generate:Biomedicines lance des essais de phase 3 pour l'anticorps contre l'asthme GB-0895

Essais De Phase 3 GB-0895 Générer : Biomédicaments Traitement De L'asthme Anticorps Conçu Par IA
PRESS RELEASE

published on 12/01/2025 at 12:05, 3 months 14 days ago

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies

AI Engineering Phase 3 Studies Generate:Biomedicines GB-0895 Severe Asthma

Accesswire

Published on 03/15/2026 at 23:25, 8 hours 22 minutes ago

Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 13 hours 47 minutes ago

SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 8 hours ago

CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 8 hours ago

Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 10 hours ago

Alset AI Announces Closing of Shares for Debt Transaction

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 07:30, 17 minutes ago

Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group revenues and Holding’s net income in the fiscal year 2025 – medium-term targets raised to 25%...
Published on 03/16/2026 at 07:24, 22 minutes ago

EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026
Published on 03/16/2026 at 07:05, 42 minutes ago

Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025
Published on 03/16/2026 at 07:02, 45 minutes ago

Changes to the Board of Directors of Julius Baer Group
Published on 03/16/2026 at 07:00, 47 minutes ago

BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start

Les Echos

Published on 03/13/2026 at 20:30, 2 days 11 hours ago

ALTAREA : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025
Published on 03/13/2026 at 20:30, 2 days 11 hours ago

ALTAREIT : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2025
Published on 03/13/2026 at 19:50, 2 days 11 hours ago

Modalités de mise à disposition du Document d’Enregistrement Universel 2025 d’ENGIE
Published on 03/13/2026 at 19:50, 2 days 11 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 13 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE

View all LES ECHOS COMFI WIRE